CHPT vs ERNA · rev $417.1M vs P/E 0.0, rev $582.0K
ChargePoint Holdings Inc (CHPT) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
ChargePoint Holdings Inc (CHPT) is a specialty retail company listed on NYSE.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported CHPT revenue for 2025-01-31 was $417.1M. Net income was -$277.1M. Revenue was down 17.7% from 2024-01-31 to 2025-01-31. CHPT currently screens at market cap $199.2M.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
CHPT currently screens at market cap $199.2M. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the CHPT and ERNA stock pages for the full models.
Not investment advice.